CSL are developing their mRNA capacity through their subsidiary - but this is independent to IDT.
Not sure if their AZ deal has an exclusivity agreement for Covid vaccines which might settle it.
$11M contract to a Tudge constituent doesn't compare to $4B to an under-performing French Company - don't think they can walk away from IDT.
The whole world needs to be vaccinated at least twice.
CSL are developing their mRNA capacity through their subsidiary...
Add IDT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
12.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $53.69M | |||
| Open | High | Low | Value | Volume |
| 12.5¢ | 12.5¢ | 12.5¢ | $18.90K | 151.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 498714 | 12.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 13.0¢ | 157806 | 2 |
View Market Depth
| Last trade - 16.10pm 29/07/2024 (20 minute delay) ? |
| IDT (ASX) Chart |